The GI SPORE Administrative Core supports projects and investigators by managing SPORE resources, communication and outreach, and by fostering the interaction among investigators, collaborators, other VICC SPOREs, other GI SPOREs, the patient and advocate community and the NCI. This management and support is accomplished by administrative and scientific meetings of SPORE investigators with oversight provided by the Internal and External Advisory Boards. Specific functions of the Core include: 1. To coordinate all GI SPORE cancer-related research 2. To administer the Developmental Research Program (DRP) 3. To administer the Career Development Program (CDP) 4. To create and prepare documents and reports to ensure compliance with federal regulations and reporting requirements 5. To monitor and manage financial resources 6. To serve as the point of contact for GI SPORE investigators and patient advocates 7. To organize and schedule GI SPORE project meetings for oversight, communication, administration, evaluation, collaboration, outreach and education 8. To coordinate communications with other GI SPOREs, VU SPOREs, VICC, VUMC, Epithelial Biology Center (EBC), Ayers Institute, Digestive Diseases Research Center (DDRDC) and collaborators 9. To organize annual External and Internal Advisory Board (EAB &IAB) meetings 10. To organize, along with the other Vanderbilt Lung and Breast SPORE administrative cores, the quarterly VICC SPORE PI meetings 11. To proactively identify academic (Meharry Medical College, Melbourne University) and pharmaceutical (GE Healthcare, Novartis) interactions that will enhance the conduct of the GI SPORE program, taking special advantage of opportunities provided through Vanderbilt's Clinical &Translational &Science Award (CTSA)

Public Health Relevance

The Administrative Core supports SPORE projects and investigators by managing SPORE resources, communication and outreach, including fostering Interaction among SPORE components and collaborators, other SPORES, the community and the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA095103-12
Application #
8557699
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
12
Fiscal Year
2013
Total Cost
$83,278
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Wang, Yang; Vnencak-Jones, Cindy L; Cates, Justin M et al. (2018) Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers. J Mol Diagn 20:366-372
Banerjee, Amrita; McKinley, Eliot T; von Moltke, Jakob et al. (2018) Interpreting heterogeneity in intestinal tuft cell structure and function. J Clin Invest 128:1711-1719
Herring, Charles A; Chen, Bob; McKinley, Eliot T et al. (2018) Single-Cell Computational Strategies for Lineage Reconstruction in Tissue Systems. Cell Mol Gastroenterol Hepatol 5:539-548
Choi, Eunyoung; Lantz, Tyler L; Vlacich, Gregory et al. (2018) Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach. Gut 67:1595-1605
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Idrees, Kamran; Padmanabhan, Chandrasekhar; Liu, Eric et al. (2018) Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma. J Surg Oncol 117:284-289
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465

Showing the most recent 10 out of 447 publications